Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Obesity and hypertension

W A Hsueh1, T A Buchanan

  • 1Department of Medicine, University of Southern California Medical Center.

Endocrinology and Metabolism Clinics of North America
|June 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Maternal obesity, gestational diabetes, breastfeeding and childhood overweight at age 2 years.

Pediatric obesity·2016
Same author

Living near a freeway is associated with lower bone mineral density among Mexican Americans.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2015
Same author

HOMA and Matsuda indices of insulin sensitivity: poor correlation with minimal model-based estimates of insulin sensitivity in longitudinal settings.

Diabetologia·2013
Same author

Effect of pioglitazone on body composition and bone density in subjects with prediabetes in the ACT NOW trial.

Diabetes, obesity & metabolism·2013
Same author

Systematic evaluation of validated type 2 diabetes and glycaemic trait loci for association with insulin clearance.

Diabetologia·2013
Same author

Insulin clearance: confirmation as a highly heritable trait, and genome-wide linkage analysis.

Diabetologia·2012
Same journal

Navigating Adrenal Disease: A Comprehensive, Practical Guide for the Clinician.

Endocrinology and metabolism clinics of North America·2026
Same journal

Adrenal Disorders in Pregnancy.

Endocrinology and metabolism clinics of North America·2026
Same journal

Diagnosis and Management of Adrenocortical Carcinoma.

Endocrinology and metabolism clinics of North America·2026
Same journal

Pheochromocytomas and Paragangliomas.

Endocrinology and metabolism clinics of North America·2026
Same journal

Hereditary Conditions Associated with Adrenocortical Carcinoma, Pheochromocytoma, and Other Adrenal Tumors: Genetic Testing and Management Recommendations.

Endocrinology and metabolism clinics of North America·2026
Same journal

Primary Bilateral Macronodular Adrenal Hyperplasia.

Endocrinology and metabolism clinics of North America·2026
See all related articles

Obesity increases hypertension risk through metabolic and cardiovascular pathways. Weight loss, exercise, and specific medications can effectively manage blood pressure and related health issues in obese individuals.

Area of Science:

  • Cardiology
  • Endocrinology
  • Metabolic Disorders

Background:

  • Obesity is linked to numerous metabolic and cardiovascular conditions, notably hypertension.
  • Excess adipose tissue, both in quantity and distribution, elevates the risk of hypertension and cardiovascular diseases.
  • Key mechanisms contributing to hypertension in obesity include sympathetic nervous system (SNS) overactivity, insulin resistance, hyperinsulinemia, sodium retention, and increased vascular reactivity.

Purpose of the Study:

  • To explore the complex relationship between obesity, metabolic dysfunction, and hypertension.
  • To review the impact of weight loss and exercise on obesity-related hypertension.
  • To discuss pharmacologic treatments for hypertension in obese patients, focusing on agents that favorably impact metabolic parameters.

Main Methods:

Related Experiment Videos

  • Review of existing literature on obesity, hypertension, and metabolic disorders.
  • Analysis of mechanisms linking obesity to elevated blood pressure.
  • Evaluation of treatment strategies, including lifestyle modifications and pharmacotherapy.

Main Results:

  • Hypertension and associated metabolic abnormalities in obese individuals often improve with weight loss and regular exercise.
  • Certain antihypertensive medications (calcium entry blockers, ACE inhibitors, alpha 1-receptor blockers) demonstrate efficacy without negatively impacting lipid and carbohydrate profiles.
  • Emerging drugs targeting insulin resistance show potential as effective antihypertensive agents for obese patients.

Conclusions:

  • Lifestyle interventions like diet and exercise are crucial for managing obesity-related hypertension.
  • Pharmacologic treatment is necessary for patients unresponsive to lifestyle changes, with specific drug classes offering benefits beyond blood pressure control.
  • Future therapeutic strategies may focus on agents that simultaneously address insulin resistance and cardiovascular risk factors in obese hypertensive individuals.